文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.

作者信息

Paulos Chrystal M, Wrzesinski Claudia, Kaiser Andrew, Hinrichs Christian S, Chieppa Marcello, Cassard Lydie, Palmer Douglas C, Boni Andrea, Muranski Pawel, Yu Zhiya, Gattinoni Luca, Antony Paul A, Rosenberg Steven A, Restifo Nicholas P

机构信息

National Cancer Institute (NCI), NIH, Bethesda, Maryland 20892-1502, USA.

出版信息

J Clin Invest. 2007 Aug;117(8):2197-204. doi: 10.1172/JCI32205.


DOI:10.1172/JCI32205
PMID:17657310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1924500/
Abstract

Lymphodepletion with total body irradiation (TBI) increases the efficacy of adoptively transferred tumor-specific CD8(+) T cells by depleting inhibitory lymphocytes and increasing homeostatic cytokine levels. We found that TBI augmented the function of adoptively transferred CD8(+) T cells in mice genetically deficient in all lymphocytes, indicating the existence of another TBI mechanism of action. Additional investigation revealed commensal gut microflora in the mesenteric lymph nodes and elevated LPS levels in the sera of irradiated mice. These findings correlated with increased dendritic cell activation and heightened levels of systemic inflammatory cytokines. Reduction of host microflora using antibiotics, neutralization of serum LPS using polymyxin B, or removal of LPS signaling components using mice genetically deficient in CD14 and TLR4 reduced the beneficial effects of TBI on tumor regression. Conversely, administration of microbial ligand-containing serum or ultrapure LPS from irradiated animals to nonirradiated antibody-lymphodepleted mice enhanced CD8(+) T cell activation and improved tumor regression. Administration of ultrapure LPS to irradiated animals further enhanced the number and function of the adoptively transferred cells, leading to long-term cure of mice with large B16F10 tumors and enhanced autoimmune vitiligo. Thus, disruption of the homeostatic balance between the host and microbes can enhance cell-based tumor immunotherapy.

摘要

相似文献

[1]
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.

J Clin Invest. 2007-8

[2]
Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling.

Clin Cancer Res. 2015-6-1

[3]
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells.

J Exp Med. 2005-10-3

[4]
Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transduction.

Cancer Immunol Immunother. 2008-5

[5]
Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8 T Cells.

Cancer Res. 2018-4-10

[6]
Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.

Immunol Cell Biol. 2011-3-8

[7]
Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning.

J Immunother Cancer. 2016-2-16

[8]
Direct recognition of LPS by human but not murine CD8+ T cells via TLR4 complex.

Eur J Immunol. 2009-6

[9]
Magnetic targeting of adoptively transferred tumour-specific nanoparticle-loaded CD8 T cells does not improve their tumour infiltration in a mouse model of cancer but promotes the retention of these cells in tumour-draining lymph nodes.

J Nanobiotechnology. 2019-8-6

[10]
Toll-like receptors in tumor immunotherapy.

Clin Cancer Res. 2007-9-15

引用本文的文献

[1]
Exploring fecal microbiota signatures associated with immune response and antibiotic impact in NSCLC: insights from metagenomic and machine learning approaches.

Front Cell Infect Microbiol. 2025-7-28

[2]
The gut microbiota in cancer immunity and immunotherapy.

Cell Mol Immunol. 2025-8-6

[3]
Gut microbiota shapes cancer immunotherapy responses.

NPJ Biofilms Microbiomes. 2025-7-25

[4]
Efficacy and safety of camrelizumab plus in the treatment of advanced esophageal squamous cell carcinoma: A single-arm, single-center, exploratory trial.

Cancer Pathog Ther. 2025-1-3

[5]
Identification of fecal microbes as potential biomarkers for early diagnosis of fatty liver disease in cattle.

Virulence. 2025-12

[6]
The Sunrise of Tertiary Lymphoid Structures in Cancer.

Immunol Rev. 2025-7

[7]
Combination strategies of gut microbiota in cancer therapy through metabolic reprogramming and immune remodeling.

Cell Commun Signal. 2025-6-5

[8]
The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development.

Nat Rev Drug Discov. 2025-6-2

[9]
Exploring the Microbiome's Impact on Glioma and Brain Metastases: Insights into Development, Progression, and Treatment Response-A Scoping Review.

Cancers (Basel). 2025-4-4

[10]
Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification.

Gut Microbes. 2025-12

本文引用的文献

[1]
Altered macrophage differentiation and immune dysfunction in tumor development.

J Clin Invest. 2007-5

[2]
Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells.

J Clin Invest. 2007-2

[3]
Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation.

Exp Hematol. 2007-2

[4]
The lymphopenic mouse in immunology: from patron to pariah.

Immunity. 2006-12

[5]
Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?

Nat Clin Pract Oncol. 2006-12

[6]
Microbial translocation is a cause of systemic immune activation in chronic HIV infection.

Nat Med. 2006-12

[7]
Hematopoietic stem-cell transplantation.

N Engl J Med. 2006-4-27

[8]
Adoptive immunotherapy for cancer: building on success.

Nat Rev Immunol. 2006-5

[9]
The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.

J Immunol. 2006-1-1

[10]
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells.

J Exp Med. 2005-10-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索